EANS-Adhoc: Semperit AG Holding Semperit postpones publication of the interim Group report for third quarter: examination of a potential impairment loss at Sempermed
--------------------------------------------------------------------------------
Disclosed inside information pursuant to article 17 Market Abuse Regulation
(MAR) transmitted by euro adhoc with the aim of a Europe-wide distribution.
The issuer is responsible for the content of this announcement.
--------------------------------------------------------------------------------
Quarterly Report
13.11.2019
Vienna - Austria, 13 November 2019 - Based on the current insights of the
Executive Board of the Semperit AG Holding into the competitive environment of
the medical business, a significant impairment loss might occur in the Medical
Sector (Sempermed segment).
The publication of the interim Group report as of 30 September 2019, which was
planned for 21 November 2019, will be postponed; the new date will be announced
separately. On 21 November 2019, a shortened reporting will be presented.
Further inquiry note:
Monika Riedel
Director Group Communications & Sustainability
+43 676 8715 8620
monika.riedel@semperitgroup.com
Judit Helenyi
Head of Investor Relations
+43 676 8715 8310
judit.helenyi@semperitgroup.com
end of announcement euro adhoc
--------------------------------------------------------------------------------
issuer: Semperit AG Holding
Modecenterstrasse 22
A-1030 Wien
phone: +43 1 79 777-310
FAX: +43 1 79 777-602
mail: judit.helenyi@semperitgroup.com
WWW: www.semperitgroup.com
ISIN: AT0000785555
indexes: ATX PRIME, WBI, ATX GP
stockmarkets: Wien
language: English